AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22735175 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavior therapy (G-CBT) plus pharmacotherapy
Number of subjects: 41
Study 22735175 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU; only pharmacotherapy)
Number of subjects: 41
Study 20211300 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse Symptoms cluster
Number of subjects: 3522
Study 20211300 — intervention group
Group type: COMPARATOR
Intervention: Classic ACS, Pain Symptoms, Stress Symptoms clusters
Number of subjects: 3522
Study 18622280 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 150
Study 18622280 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated mycophenolate sodium (EC-MPS)
Number of subjects: 150
Study 16135476 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for chronic insomnia
Number of subjects: 57
Study 16135476 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition (WLC)
Number of subjects: 57
Study 16135476 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treated groups (CBT and WLC)
Number of subjects: 57
Study 16135476 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up measures
Number of subjects: 57
Study 11812507 — intervention group
Group type: EXPERIMENTAL
Intervention: High-yield non-menthol cigarettes
Number of subjects: 36
Study 11812507 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial cigarettes
Number of subjects: 36
Study 11812507 — intervention group
Group type: COMPARATOR
Intervention: Low-yield cigarettes
Number of subjects: 36
Study 11812507 — intervention group
Group type: COMPARATOR
Intervention: Menthol and non-menthol cigarettes
Number of subjects: 36
Study 10624328 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 102
Study 10624328 — intervention group
Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 102
Study 7560222 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution A (0.06% triclosan + 2% tween 80)
Number of subjects: 10
Study 7560222 — intervention group
Group type: COMPARATOR
Intervention: Solution B (0.06% triclosan + 0.25% sodium lauryl sulphate)
Number of subjects: 10
Study 1935152 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (1 mmol/kg body weight)
Number of subjects: 10
Study 1935152 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (control)
Number of subjects: 10
Study 6991994 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 36
Study 6991994 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 36
Study 31644515 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (DEX) 1.5 μg/kg
Number of subjects: 134
Study 31644515 — intervention group
Group type: COMPARATOR
Intervention: Intranasal saline (Placebo)
Number of subjects: 134
Study 31103605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy
Number of subjects: 0
Study 27804204 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter A: Poliflux®RevaclearMAX
Number of subjects: 41
Study 27804204 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter B: Helixone®Fx80
Number of subjects: 41
Study 27804204 — intervention group
Group type: EXPERIMENTAL
Intervention: Filter C: Polyflux®H210
Number of subjects: 41
Study 26452988 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1085
Study 26452988 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1085
Study 23565740 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 44
Study 23565740 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride (individually titrated up to 4 mg)
Number of subjects: 44
Study 23565740 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Vildagliptin and Glimepiride)
Number of subjects: 44
Study 21098799 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1 mg/kg bolus, 0.5 mg/kg top-up if needed) with fentanyl (3 μg/kg bolus)
Number of subjects: 40
Study 21098799 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.1 mg/kg bolus, 0.1 mg/kg top-up if needed) with fentanyl (3 μg/kg bolus)
Number of subjects: 40
Study 19245728 — intervention group
Group type: EXPERIMENTAL
Intervention: Helios oxygen system
Number of subjects: 39
Study 19245728 — intervention group
Group type: EXPERIMENTAL
Intervention: HomeFill oxygen system
Number of subjects: 39
Study 19245728 — intervention group
Group type: EXPERIMENTAL
Intervention: FreeStyle oxygen system
Number of subjects: 39
Study 19245728 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed-oxygen cylinder system
Number of subjects: 39
Study 17084252 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 10001
Study 17084252 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/day
Number of subjects: 10001
Study 15126653 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolotherapy
Number of subjects: 70
Study 15126653 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 70
Study 11487075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic varix ligation with internal spermatic artery (ISA) preservation (Group A)
Number of subjects: 25
Study 11487075 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic varix ligation with ISA ligation (Group B)
Number of subjects: 25
Study 11487075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic varix ligation with ISA preservation (Group A)
Number of subjects: 25
Study 9257379 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.025% applied nightly
Number of subjects: 48
Study 9257379 — intervention group
Group type: COMPARATOR
Intervention: Placebo applied nightly
Number of subjects: 48
Study 9257379 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 48
Study 9257379 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.025%
Number of subjects: 48
Study 8302412 — intervention group
Group type: EXPERIMENTAL
Intervention: High flux hemodialysis
Number of subjects: 21
Study 8302412 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 21
Study 3087310 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 13
Study 3087310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 30883516 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) 5 mg/kg every 4 weeks for up to 20 weeks
Number of subjects: 47
Study 29877964 — intervention group
Group type: EXPERIMENTAL
Intervention: ECT plus antipsychotic drugs (APD)
Number of subjects: 31
Study 29877964 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic drugs (APD) only
Number of subjects: 31
Study 29877964 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined patient groups (ECT + APD and APD only)
Number of subjects: 31
Study 29877964 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparisons
Number of subjects: 31
Study 27093702 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIAN LD‐735 wrist blood pressure monitor
Number of subjects: 33
Study 24930728 — intervention group
Group type: EXPERIMENTAL
Intervention: Losmapimod (7.5 mg or 15.0 mg loading dose followed by 7.5 mg twice daily)
Number of subjects: 526
Study 24930728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study 21697747 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 47
Study 21697747 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance Training (ET)
Number of subjects: 47
Study 21697747 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 47
Study 21697747 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 20956620 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + CON
Number of subjects: 333
Study 20956620 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 333
Study 18976980 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly structured training method (18-step approach)
Number of subjects: 16
Study 18976980 — intervention group
Group type: COMPARATOR
Intervention: Conventional training method (9-step approach)
Number of subjects: 16
Study 15750868 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent mapping (CM)
Number of subjects: 0
Study 15750868 — intervention group
Group type: EXPERIMENTAL
Intervention: Varied mapping (VM)
Number of subjects: 0
Study 15750868 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-task blocks
Number of subjects: 0
Study 15750868 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-switch trials
Number of subjects: 0
Study 15750868 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure and mixed tasks (between-participants)
Number of subjects: 0
Study 12492263 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured motivational enhancement program
Number of subjects: 64
Study 10323159 — intervention group
Group type: EXPERIMENTAL
Intervention: Two coats of a copal varnish
Number of subjects: 76
Study 10323159 — intervention group
Group type: EXPERIMENTAL
Intervention: A dentin adhesive resin liner
Number of subjects: 76
Study 10323159 — intervention group
Group type: COMPARATOR
Intervention: No liner
Number of subjects: 76
Study 10323159 — intervention group
Group type: COMPARATOR
Intervention: A resin‐modified glass‐ionomer liner
Number of subjects: 76
Study 8955549 — intervention group
Group type: EXPERIMENTAL
Intervention: Training procedure to improve Wisconsin Card Sorting Test performance
Number of subjects: 10
Study 8955549 — intervention group
Group type: COMPARATOR
Intervention: No monetary incentive
Number of subjects: 10
Study 1657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalaprilat (0.2-1.2 mg, mean 1.0 mg) administered as bolus to 20 patients
Number of subjects: 48
Study 1657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalaprilat (1 mg) administered as infusion over two hours to 20 patients
Number of subjects: 48
Study 1657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalaprilat (1 mg) administered as infusion over two hours to 8 patients with systolic blood pressure between 100-109 mmHg
Number of subjects: 48
Study 1657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous enalaprilat
Number of subjects: 48
Study 1657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral enalapril (2.5-10 mg/day) continued after intravenous treatment
Number of subjects: 48
Study 1657799 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (thrombolytic treatment, intravenous metoprolol, intravenous nitroglycerin, intravenous furosemide)
Number of subjects: 48
Study 7041943 — intervention group
Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (CP) immunotherapy
Number of subjects: 92
Study 7041943 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study 31368770 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine (50 mg)
Number of subjects: 0
Study 31368770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31368770 — intervention group
Group type: EXPERIMENTAL
Intervention: d-cycloserine
Number of subjects: 0
Study 31368770 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management
Number of subjects: 0
Study 31603565 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate chronic kidney disease (CKD) patients
Number of subjects: 270
Study 31603565 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported awareness of periodontal conditions
Number of subjects: 270
Study 28419106 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention
Number of subjects: 16
Study 28419106 — intervention group
Group type: COMPARATOR
Intervention: Control facilities
Number of subjects: 16
Study 26787012 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Valgus Correction Angle (VCA)
Number of subjects: 133
Study 26787012 — intervention group
Group type: COMPARATOR
Intervention: Fixed Valgus Correction Angle (VCA)
Number of subjects: 133
Study 24975467 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise (RVE)
Number of subjects: 14
Study 24975467 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 14
Study 24975467 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14
Study 21509432 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepaid cash incentive of $5
Number of subjects: 638
Study 21509432 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupon for diapers valued at $6
Number of subjects: 638
Study 21509432 — intervention group
Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 638
Study 19507140 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Glutaraldehyde (GD)
Number of subjects: 64
Study 19507140 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.5% Grape seed extract (GSE)
Number of subjects: 64
Study 19507140 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% Genipin (GE)
Number of subjects: 64
Study 19507140 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 64
Study 17616862 — intervention group
Group type: EXPERIMENTAL
Intervention: pioglitazone
Number of subjects: 192
Study 17616862 — intervention group
Group type: EXPERIMENTAL
Intervention: glimepiride
Number of subjects: 192
Study 16083704 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin (600 mg/day for 1 week)
Number of subjects: 30
Study 16083704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (1 g/day for 3 weeks)
Number of subjects: 30
Study 16083704 — intervention group
Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 30
Study 12219865 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated desirability of items that can be purchased with income in Study 1
Number of subjects: 0
Study 12219865 — intervention group
Group type: EXPERIMENTAL
Intervention: Income enabling purchase of desired items in Study 2
Number of subjects: 0
Study 12219865 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparisons with a person's past in Study 3
Number of subjects: 0
Study 12219865 — intervention group
Group type: EXPERIMENTAL
Intervention: Social comparison in Study 3
Number of subjects: 0
Study 10347293 — intervention group
Group type: EXPERIMENTAL
Intervention: Body temperature CO2 pneumoperitoneum
Number of subjects: 30
Study 10347293 — intervention group
Group type: COMPARATOR
Intervention: Room temperature CO2 pneumoperitoneum
Number of subjects: 30
Study 7577895 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g textured vegetable protein (TVP)/d, containing 45 mg conjugated isoflavones
Number of subjects: 15
Study 7577895 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g miso/d, containing 25 mg unconjugated isoflavones
Number of subjects: 15
Study 7577895 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 g TVP/d, containing 23 mg conjugated isoflavones
Number of subjects: 15
Study 7577895 — intervention group
Group type: COMPARATOR
Intervention: 60 g of a soyabean product with chemically extracted isoflavones (Arcon F)
Number of subjects: 15
Study 7577895 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg conjugated isoflavones as 60 g TVP
Number of subjects: 15
Study 7577895 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg conjugated isoflavones
Number of subjects: 15
Study 7577895 — intervention group
Group type: COMPARATOR
Intervention: 23 mg conjugated isoflavone-free Arcon F
Number of subjects: 15
Study 1962157 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck school reinforced with compliance enhancing measures (group B)
Number of subjects: 0
Study 1962157 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional neck school (group A)
Number of subjects: 0
Study 1962157 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 0
Study 7062228 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemetry monitoring
Number of subjects: 60
Study 7062228 — intervention group
Group type: COMPARATOR
Intervention: Cardiotocography monitoring (Control)
Number of subjects: 60
Study 31637668 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg or 250 mg daily for a 4-week cycle)
Number of subjects: 20
Study 29022390 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus reuteri DSM 17938 (LR DSM 17938) administered for 105 days, double dosage of 4×10^8 cfu for the first 15 days, followed by standard dosage of 2×10^8 cfu
Number of subjects: 56
Study 29022390 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus reuteri DSM 17938 (LR DSM 17938)
Number of subjects: 56
Study 29022390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 26688435 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsion S
Number of subjects: 10
Study 26688435 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsion N
Number of subjects: 10
Study 26688435 — intervention group
Group type: COMPARATOR
Intervention: Oil capsules
Number of subjects: 10
Study 24724887 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 107
Study 24724887 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 107
Study 24724887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 24724887 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram with placebo
Number of subjects: 107
Study 24724887 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram with naltrexone
Number of subjects: 107
Study 22529026 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% moxifloxacin
Number of subjects: 63
Study 22529026 — intervention group
Group type: COMPARATOR
Intervention: 0.3% gatifloxacin
Number of subjects: 63
Study 22529026 — intervention group
Group type: COMPARATOR
Intervention: 0.5% levofloxacin
Number of subjects: 63
Study 20831465 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge (measured by KASE questionnaire)
Number of subjects: 180
Study 20831465 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude (measured by KASE questionnaire)
Number of subjects: 180
Study 20831465 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy (measured by KASE questionnaire)
Number of subjects: 180
Study 20831465 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Quality of Life (measured by AQLQ)
Number of subjects: 180
Study 18483000 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventricular arrhythmia bursts during or subsequent to reperfusion
Number of subjects: 157
Study 18483000 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher absolute peak ST segments and more frequent worsening of ST elevation immediately after reperfusion
Number of subjects: 157
Study 16229019 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg b.i.d.
Number of subjects: 16
Study 16229019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 14607319 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated analysis using conventional spin echo (SE) MRI sequence
Number of subjects: 13
Study 14607319 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated analysis
Number of subjects: 13
Study 14607319 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D multi-slice sequences (SE and FLAIR) with fully automated analysis
Number of subjects: 13
Study 14607319 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm of a clinical trial
Number of subjects: 13
Study 10834685 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous dilational tracheostomy (PDT)
Number of subjects: 56
Study 10834685 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical tracheostomy (ST)
Number of subjects: 56
Study 8557138 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol 600 mg/d for 2 to 4 weeks (n = 15)
Number of subjects: 30
Study 8557138 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide acetate depot 3.75 mg for 2 months (n = 15)
Number of subjects: 30
Study 2061442 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% scalp application
Number of subjects: 378
Study 2061442 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 378
Study 6125562 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants alone
Number of subjects: 64
Study 6125562 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy
Number of subjects: 64
Study 6125562 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antipsychotic and antidepressant medication
Number of subjects: 64
Study 30856181 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal ketamine and midazolam (KMIN)
Number of subjects: 84
Study 30856181 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine and midazolam (KMO)
Number of subjects: 84
Study 30856181 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam (MO)
Number of subjects: 84
Study 30856181 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 84
Study 28499420 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal morphine (100 mcg)
Number of subjects: 39
Study 28499420 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block plus single-shot sciatic nerve block
Number of subjects: 39
Study 26472133 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (individual counselling sessions on nutrition, physical activity, and weight monitoring)
Number of subjects: 250
Study 26472133 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine prenatal care and an information leaflet)
Number of subjects: 250
Study 26472133 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole study cohort
Number of subjects: 250
Study 26472133 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group infants
Number of subjects: 250
Study 26472133 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake and macronutrient composition during pregnancy
Number of subjects: 250
Study 24716637 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1000 IU/day)
Number of subjects: 84
Study 24716637 — intervention group
Group type: COMPARATOR
Intervention: Control (nonsupplementation)
Number of subjects: 84